PHARMAMED
ActiveFinancials · financial year 2025, full format
Annual accounts 2025 filed on 05-06-2026 PDF all 33 filings
2020 to 2025, 5 financial years 2018 to 2025, 7 financial years
The operating result for 2025 is 75% higher than in 2024. It is the second rise in a row, after the fall in 2023.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Average staff per financial year, in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Wholesale trade (NACE 46). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio, return on assets (ROA) and staff (FTE).
- 2023 Net result -75% on 2022. This financial year ran 15 months, the previous one 21.
Comparable companies
These companies have the same main activity as PHARMAMED: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €1.3m and €2m, founded between 1991 and 1997.
| Company | Founded | Total assets | Equity | Gross margin | Net result | FTE | Financial year |
|---|---|---|---|---|---|---|---|
| PHARMAMED Anderlecht | 1991 | €1.4m | €0.4m | €0.5m | €0.2m | 6.2 | 2025 |
| ECOMAR Ath | 1991 | €1.4m | €0.9m | €0.6m | €0.2m | 5.8 | 2025 |
| H.D.P. MEDICAL Waasmunster | 1992 | €1.3m | €0.3m | €0.8m | €0.09m | 6.6 | 2025 |
| YVSOLAB Turnhout | 1992 | €2.0m | €0.7m | €0.8m | €0.2m | 7 | 2025 |
| NUTRIFARMA Heist-op-den-Berg | 1996 | €1.8m | €1.4m | €0.6m | €0.2m | 4.6 | 2025 |
| MD MEDICAL Namur | 1993 | €1.5m | €0.8m | €0.9m | €0.2m | 7.5 | 2025 |
| SAMCON Sint-Niklaas | 1997 | €1.4m | €0.6m | €0.6m | €0.08m | 4.3 | 2025 |
They were chosen from the 1,134 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
Companies with the same profile, two years later
Historical observationIn July 2024, 31,368 companies had the same profile as PHARMAMED has now. Two years later, 0.5% had gone bankrupt and 93.5% were still going.
- Micro
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of PHARMAMED itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,368 companies, not a prediction for PHARMAMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Public contracts
Source: TED (Tenders Electronic Daily), Publications Office of the European Union. The values are as the buyer published them. For a framework agreement, the value is a ceiling.
| Line | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | €0.003m | €0.01m | €239 | - | - |
| Remuneration, social security and pensions62 | - | - | - | €0.3m | €0.2m | €0.2m | €0.3m | ▲ 26.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €0.02m | €0.02m | €0.01m | €0.03m | €0.04m | €0.05m | €0.06m | ▲ 23.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | €0.02m | €0.01m | €0.008m | €0.001m | ▼ 84.3% |
| Other operating charges640/8 | - | - | - | €0.01m | €0.01m | €0.03m | €0.008m | ▼ 74.7% |
| Non-recurring operating charges66A | - | - | - | €0 | - | €80 | - | - |
| Gross operating margin9900 | €0.3m | €0.3m | €1.4m | €0.6m | €0.3m | €0.4m | €0.5m | ▲ 30.1% |
| Operating profit (loss)9901 | €0.1m | €0.1m | €1.2m | €0.2m | €0.04m | €0.1m | €0.2m | ▲ 75.4% |
| Financial income75/76B | - | - | - | €0.008m | €0.02m | €0.03m | €0.009m | ▼ 71.4% |
| Recurring financial income75 | €0.03m | €0.001m | €0.002m | €0.008m | €0.02m | €0.03m | €0.009m | ▼ 71.4% |
| Financial charges65/66B | - | - | - | €0.03m | €0.02m | €0.01m | €0.006m | ▼ 41.0% |
| Recurring financial charges65 | €0.01m | €0.03m | €0.03m | €0.03m | €0.02m | €0.01m | €0.006m | ▼ 41.0% |
| Profit (loss) for the period before taxes9903 | €0.1m | €0.09m | €1.1m | €0.2m | €0.04m | €0.1m | €0.2m | ▲ 51.2% |
| Income taxes67/77 | €0.007m | €0.006m | €0.01m | €0.03m | €0.008m | €0.008m | €0.02m | ▲ 127% |
| Profit (loss) for the period9904 | €0.1m | €0.09m | €1.1m | €0.1m | €0.04m | €0.1m | €0.2m | ▲ 46.5% |
| Transfer from tax-exempt reserves789 | - | - | - | €0.02m | €0 | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €0.1m | €0.09m | €1.1m | €0.2m | €0.04m | €0.1m | €0.2m | ▲ 46.5% |
| Line | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €0.8m | €0.9m | €1.8m | €1.0m | €1.1m | €1.3m | €1.4m | ▲ 9.1% |
| Fixed assets21/28 | €0.04m | €0.02m | €0.01m | €0.07m | €0.2m | €0.2m | €0.1m | ▼ 15.7% |
| Intangible fixed assets21 | €0.02m | €0.01m | €0.005m | €0 | - | €0.03m | €0.03m | ▲ 1.8% |
| Tangible fixed assets22/27 | €0.02m | €0.01m | €0.004m | €0.06m | €0.2m | €0.1m | €0.1m | ▼ 20.1% |
| Plant, machinery and equipment23 | - | - | - | €488 | €0 | €0.002m | €0.001m | ▼ 36.1% |
| Furniture and vehicles24 | - | - | - | €0.06m | €0.2m | €0.1m | €0.1m | ▼ 20.1% |
| Other tangible fixed assets26 | - | - | - | - | €0.05m | €0.004m | €0.004m | ▼ 11.2% |
| Financial fixed assets28 | €0.002m | €260 | €0.003m | €0.008m | €0.009m | €0.005m | €0.005m | = |
| Current assets29/58 | €0.8m | €0.8m | €1.8m | €0.9m | €0.9m | €1.2m | €1.3m | ▲ 12.8% |
| Stocks and contracts in progress3 | €0.2m | €0.3m | €0.2m | €0.2m | €0.3m | €0.4m | €0.4m | ▲ 5.6% |
| Stocks30/36 | - | - | - | €0.2m | €0.3m | €0.4m | €0.4m | ▲ 5.6% |
| Amounts receivable within one year40/41 | €0.5m | €0.4m | €0.8m | €0.3m | €0.3m | €0.5m | €0.5m | ▼ 6.6% |
| Trade receivables40 | - | - | - | €0.3m | €0.3m | €0.5m | €0.5m | ▼ 2.6% |
| Other amounts receivable41 | - | - | - | €0.005m | €0.004m | €0.04m | €0.02m | ▼ 53.8% |
| Current investments50/53 | €0.02m | €0.03m | €0.04m | €0.07m | €0.07m | - | - | - |
| Cash at bank and in hand54/58 | €0.1m | €0.2m | €0.7m | €0.3m | €0.2m | €0.3m | €0.4m | ▲ 58.9% |
| Deferred charges and accrued income490/1 | - | - | - | €0.003m | €0.003m | - | €0.008m | - |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €0.8m | €0.9m | €1.8m | €1.0m | €1.1m | €1.3m | €1.4m | ▲ 9.1% |
| Equity10/15 | €0.3m | €0.3m | €0.3m | €0.4m | €0.4m | €0.4m | €0.4m | ▲ 9.1% |
| Contributions10/11 | €0.06m | €0.06m | €0.06m | €0.06m | €0.06m | €0.06m | €0.06m | = |
| Capital10 | - | - | - | €0.06m | €0.06m | €0.06m | €0.06m | = |
| Issued capital100 | - | - | - | €0.06m | €0.06m | €0.06m | €0.06m | = |
| Reserves13 | €0.2m | €0.2m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | = |
| Non-distributable reserves130/1 | - | - | - | €0.006m | €0.006m | €0.006m | €0.006m | = |
| Legal reserve130 | - | - | - | €0.006m | €0.006m | €0.006m | €0.006m | = |
| Tax-exempt reserves132 | - | - | - | €0.007m | €0.007m | €0.007m | €0.007m | = |
| Distributable reserves133 | - | - | - | €0.3m | €0.3m | €0.3m | €0.3m | = |
| Profit (loss) carried forward14 | - | - | - | €0 | €0 | €0.03m | €0.06m | ▲ 134% |
| Amounts payable17/49 | €0.5m | €0.6m | €1.5m | €0.6m | €0.7m | €0.9m | €1.0m | ▲ 9.1% |
| Amounts payable after more than one year17 | €0.02m | €0.006m | €0 | €0.02m | €0.05m | €0.03m | €0.01m | ▼ 55.7% |
| Financial debts170/4 | - | - | - | €0.02m | €0.05m | €0.03m | €0.01m | ▼ 55.7% |
| Amounts payable within one year42/48 | €0.5m | €0.6m | €1.5m | €0.6m | €0.7m | €0.9m | €1.0m | ▲ 11.2% |
| Current portion of amounts payable after more than one year42 | - | - | - | €0.009m | €0.02m | €0.02m | €0.02m | ▼ 22.9% |
| Trade debts44 | €0.1m | €0.3m | €0.2m | €0.4m | €0.6m | €0.7m | €0.7m | ▲ 6.8% |
| Suppliers440/4 | - | - | - | €0.4m | €0.6m | €0.7m | €0.7m | ▲ 6.8% |
| Taxes, remuneration and social security45 | - | - | - | €0.03m | €0.07m | €0.07m | €0.08m | ▲ 11.4% |
| Taxes450/3 | - | - | - | €0.01m | €0.03m | €0.04m | €0.05m | ▲ 29.5% |
| Remuneration and social security454/9 | - | - | - | €0.02m | €0.03m | €0.03m | €0.02m | ▼ 16.1% |
| Other amounts payable47/48 | - | - | - | €0.1m | €0.03m | €0.1m | €0.2m | ▲ 43.3% |
| Line | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €0.1m | €0.09m | €1.1m | €0.1m | €0.04m | €0.1m | €0.2m | ▲ 46.5% |
| + Depreciation and write-downs630 | €0.02m | €0.02m | €0.01m | €0.03m | €0.04m | €0.05m | €0.06m | ▲ 23.1% |
| Operating cash flow (approximation) | €0.2m | €0.1m | €1.1m | €0.2m | €0.07m | €0.2m | €0.2m | ▲ 39.9% |
| Investment in fixed assets (approximation) | - | €251 | -€0.003m | - | -€0.2m | €0.01m | -€0.04m | - |
| Change in cash | - | €0.04m | €0.5m | - | -€0.1m | €0.08m | €0.2m | ▲ 102% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Latest 10 of 33 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | full format | 05-06-2026 | 2026-00140315 | |
| 31-12-2024 | full format | 16-07-2025 | 2025-00281654 | |
| 31-12-2023 | full format | 23-08-2024 | 2024-00371624 | |
| 30-09-2022 | full format | 25-05-2023 | 2023-00095919 | |
| 31-12-2020 | full format | 19-08-2021 | 2021-50600080 | |
| 31-12-2019 | full format | 28-08-2020 | 2020-50100310 | |
| 31-12-2018 | full format | 29-08-2019 | 2019-56100426 | |
| 31-12-2017 | full format | 28-08-2018 | 2018-55700090 | |
| 31-12-2016 | full format | 21-08-2017 | 2017-45900002 | |
| 31-12-2015 | full format | 29-08-2016 | 2016-50300249 |